Literature DB >> 30913992

Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging.

Andrew T Turk1, Sylvia L Asa2, Zubair W Baloch3, William C Faquin4, Giovanni Fellegara5, Ronald A Ghossein6, Thomas J Giordano7, Virginia A LiVolsi3, Ricardo Lloyd8, Ozgur Mete2, Juan Rosai9, Saul Suster10, Lester D R Thompson11, Bruce M Wenig12.   

Abstract

Background: Extrathyroidal extension (ETE) by papillary and follicular thyroid carcinoma can be associated with increased risk of tumor recurrence and mortality. In the seventh edition of its Cancer Staging Manual, the American Joint Committee on Cancer (AJCC) defined minimal ETE as the involvement of skeletal muscle (i.e., strap muscles) or perithyroidal soft tissue. The eighth edition of the AJCC Cancer Staging Manual has changed the criteria so that only grossly evident (macroscopic) ETE involving strap muscles (not microscopic ETE involving perithyroidal soft tissue) affects tumor staging. Summary: Concordance of identifying microscopic ETE (as well as extranodal extension by carcinoma metastatic to lymph nodes) was previously evaluated among 11 expert endocrine pathologists. The overall agreement rate was slight when rendering a diagnosis of ETE. Concordance was highest when pathologists assessed the spatial relationship of carcinoma to skeletal muscle. This article discusses the significance of these findings. It also reviews relevant anatomic and developmental considerations related to the boundaries of the thyroid. Conclusions: The results of the concordance study provide additional rationale supporting stringent criteria for diagnosing ETE, as proposed by the eighth edition of the AJCC Cancer Staging Manual. It is expected that these rigid morphologic criteria will potentially reduce interobserver variability and enhance consistency in the diagnosis and staging of thyroid carcinoma.

Entities:  

Keywords:  AJCC eighth edition; extrathyroidal extension; pathology; staging; thyroid cancer

Year:  2019        PMID: 30913992     DOI: 10.1089/thy.2018.0286

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

1.  Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma.

Authors:  Antonella Verrienti; Antonella Carbone; Domenico Savio Cito; Marialuisa Sponziello; Valeria Pecce; Rocco Bruno
Journal:  Endocrine       Date:  2020-12-04       Impact factor: 3.633

2.  Concepts of Pathological Staging and Prognosis in Papillary Thyroid Carcinoma.

Authors:  Alfred K Lam
Journal:  Methods Mol Biol       Date:  2022

3.  Predictive value of LN metastasis detected by 18F-FDG PET/CT in patients with papillary thyroid cancer receiving iodine-131 radiotherapy.

Authors:  Chao Li; Jian Zhang; Hui Wang
Journal:  Oncol Lett       Date:  2019-06-19       Impact factor: 2.967

4.  Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients.

Authors:  Jianlu Song; Ting Yan; Wangwang Qiu; Youben Fan; Zhili Yang
Journal:  Cancer Manag Res       Date:  2020-04-09       Impact factor: 3.989

5.  Does Locally Advanced Thyroid Cancer Have Different Features? Results from a Single Academic Center.

Authors:  Marco Dell'Aquila; Pietro Tralongo; Giuseppe De Ruggieri; Mariangela Curatolo; Luca Revelli; Celestino Pio Lombardi; Alfredo Pontecorvi; Guido Fadda; Luigi Maria Larocca; Marco Raffaelli; Liron Pantanowitz; Esther Diana Rossi
Journal:  J Pers Med       Date:  2022-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.